A molecular fingerprint for medulloblastoma

Area of Science:

• Neuro-oncology
• Molecular biology
• Genetics

Background:

• Medulloblastoma is the most common malignant pediatric brain tumor.
• Mouse models with genetic alterations in Ptc1, DNA repair, cell cycle regulation, and p53 pathways predispose to medulloblastoma.
• Understanding the genetic underpinnings of medulloblastoma is critical for developing targeted therapies.

Purpose of the Study:

• To identify genes specifically involved in medulloblastoma development and tumorigenesis.
• To compare gene expression profiles between mouse medulloblastomas and developing cerebellum.
• To investigate the relevance of identified genes in human medulloblastomas.

Main Methods:

• Gene expression profiling of medulloblastomas from genetically engineered mice.
• Comparative analysis of gene expression in tumors versus normal developing cerebellum.
• Validation of gene expression changes in a subset of human medulloblastomas.

Main Results:

• Medulloblastoma expression profiles were highly similar among tumors and resembled developing cerebellum.
• Twenty-one genes were specifically up-regulated in medulloblastomas.
• Key up-regulated genes included sFrp1, Ptc2, and Math1, which are involved in cerebellar development signaling pathways.
• Coordinated deregulation of these genes was observed in a significant portion of human medulloblastomas.

Conclusions:

• A specific set of genes, including sFrp1, Ptc2, and Math1, are centrally deregulated in medulloblastoma.
• These genes play a critical role in medulloblastoma tumorigenesis.
• The identified gene group represents potential therapeutic targets for pediatric medulloblastoma.